Ryan Madson goes on the DL with a broken toe after kicking a chair

6 Comments

Big Toe.gifBrad Lidge came off the disabled list today, and as Aaron pointed out yesterday, there is an open question as to whether he jumps right back into his customary role as the Phillies’ mediocre closer or if, instead, Ryan Madson will retain the job of Phillies’ mediocre closer for the time being.

Or at least there was a question: MLB.com’s Todd Zolecki reports that Madson has been placed on the disabled list with a broken big toe* that he suffered after Wednesday’s game in San Francisco. Which he wouldn’t have been in in the first place if Brian Wilson hadn’t blown that save, so let’s just blame all this on Bruce Bochy, shall we?

Wait — he suffered the injury after Wednesday’s game? Yep! Which either means (a) somebody kicked something after blowing a save; or (b) Brad Lidge hired someone to go after Madson, Tonya Harding-style.  Man, I really hope it’s (b). That would feed the maw of this blog for three months, easy.  UPDATE: Madson kicked a chair. I guess there goes the dream of reporting on a juicy scandal.

Anyway, Antonio Bastardo gets called up to replace Madson on the roster. I think we can safely assume that Lidge is the man in the ninth inning now.

*Actually Zolecki says “great toe,” but I’m using the soda/pop rule of
grammar, which allows me to use phrases with which I feel more
comfortable.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.